Pill known as OXO-001, designed to act directly on womb lining, could improve rate of embryo implantation
A trial of a new fertility drug has shown that it could improve the rate of embryo implantation during IVF and lead to a 7% increase in live births.
The pill, known as OXO-001, is designed to act directly on the lining of the womb to make it more receptive to the embryo being implanted. The findings raise hope for patients who have experienced repeated implantation failures during successive rounds of IVF.
About Author
More Stories
Virologist Wendy Barclay: ‘Wild avian viruses are mixing up their genetics all the time. It’s like viral sex on steroids’
Microsoft unveils chip it says could bring quantum computing within years
Shortsighted Taiwan may have lessons for the world as a preventable disease skyrockets